Person

Joseph A. Sowell III

Formerly SVP; Chief Development Officer, HCA Healthcare

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$30.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • HCA
    HCA Healthcare
    SVP; Chief Development Officer
    2016 or earlier – last filing Aug 2024

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 28, 2022HCASale12,946$223.18$2.9M
Mar 11, 2022HCASale11,522$269.00$3.1M
Jan 4, 2022HCASale22,198$259.23$5.8M
Feb 4, 2020HCASale21,309$145.00$3.1M
Jan 29, 2020HCASale31,063$145.30$4.5M
Feb 1, 2018HCASale16,830$101.23$1.7M
Feb 1, 2018HCASale13,365$100.76$1.3M
Jan 30, 2018HCASale22,025$101.86$2.2M
Jan 26, 2018HCASale58,175$95.00$5.5M

SEC reporting-owner ID (CIK) 1478415 · all filings on EDGAR